ANTIGENICS (NASDAQ:AGEN)

0.90

0.06 (6.25%)

ANTIGENICS (NASDAQ:AGEN) Delayed :
Previous Close	$0.96	52 Week High	$3.34
Open	$0.91	52 Week Low	$0.19
Day High	$0.94	P/E	N/A
Day Low	$0.88	EPS	$-0.35
Volume	959,313
More AGEN Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
GSK	3	ONTY	2
BANR	2	ALVR	2
NITE	2	CASB	2
CYTR	2	PLCM	2
AIB	2	CHIP	2
SVNT	2	CKSW	2

View All Entities

Nov 20, 2009 08:30 AM Antigenics (AGEN) Kidney Cancer Treatment Oncophage Receives Negative Opinion from CHMP
Nov 19, 2009 04:48 PM Antigentics (AGEN) Announces 8.5M Common Shelf
Nov 4, 2009 09:27 AM Antigenics (AGEN) Indicated that Glaxo's malaria Vaccine Phase III Enrolled 5000 Children to Date
Oct 29, 2009 07:55 AM Antigenics (AGEN) Posts Q3 Loss of $0.13, Revs Up Y/Y
Oct 21, 2009 01:35 PM Unusual 11 Mid-Day Movers 10/21: CASB, HMNF, SPDE, CHIP Higher; AGEN, TSFG, CKSW, NITE Lower

Nov 20, 2009 08:25AM European CHMP Formally Adopts Negative Opinion on Oncophage(R)
Nov 4, 2009 07:00AM Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 Adjuvant
Oct 29, 2009 07:00AM Antigenics Reports Third Quarter 2009 Financial Results
Oct 26, 2009 07:00AM Data Presented on Oncophage(R) Cancer Vaccine in Recurrent Glioma at SNO 2009
Oct 22, 2009 07:00AM Antigenics to Report Third Quarter 2009 Financial Results on October 29, 2009; Conference Call to Follow

Nov 3, 2009 09:08 AM Four Biotech Stocks to Play the Sector Pullback
Oct 29, 2009 04:01 PM Antigenics Q3 2009 Earnings Call Transcript
Oct 29, 2009 06:51 AM BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?
Oct 28, 2009 02:47 PM Biotech Sector Pullback: Good Time to Buy at a Discount
Oct 28, 2009 09:59 AM Investing in Stocks of Various Price Levels: What Really Constitutes a Penny Stock?

No comments are currently available.